Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Novel analytical strategies and tools for cell and gene therapies - WHITEPAPER

Share this article

The roadmap for non-traditional biologics, such as cell therapies, gene therapies and gene-edited cell therapies, is sometimes vague and can lead to many challenges.

This whitepaper examines the latest analytical approaches and tools to optimize production processes such as characterization, stability and release testing.

The paper also explores:

  • Vector characterization and cell potency assays
  • Flow cytometry to classify the phenotype of cell therapy products
  • Rapid Sterility Testing
  • New technologies for cell enumeration & viability
  • mRNA therapies
  • Off-target effects
  • Machine Learning & Artificial Intelligence

Click the image at the top of the page or here to explore the whitepaper.

This piece represents the views of the author and not necessarily the views of Informa Connect Life Sciences.

Share this article

Upcoming event

Cell Therapy Manufacturing Asia

05 - 08 Apr 2021
The ONLY Cell and Gene Therapy event in Asia to help you fast track manufacturing & commercialization across borders
Go to site